Figure 2.

Incidence of oral candidiasis during one chemotherapy cycle and associated changes in salivary flow and neutrophil surveillance. (A) Oral candidiasis incidence. (B–D) Changes in salivary flow rate, peripheral neutrophil counts, and oral neutrophil counts between baseline and the first visit with candidiasis. (E,F) Changes between baseline and V4 in the ability of peripheral neutrophils to kill C. albicans in all cancer subjects and in subjects that tested positive for oral candidiasis, during the cycle. * indicates a p value < 0.05, when comparing subject-matched data via Wilcoxon Rank tests.